This study reviews the many uses for waste generated from acerola (Malpighia spp.) production, a tropical fruit renowned for its nutrient-rich content. Traditionally considered an environmental burden, this waste is now gaining attention for its sustainable applications in green technology. This review outlines the extraction of valuable bioactive compounds, like polyphenols, carotenoids, and pectin, that can be extracted from the acerola fruit and acerola waste, and it also delves into its potential in materials science, particularly in the creation of pharmaceutical formulations, nanomaterials, composites, biofuels, and energy applications. On the medical front, the paper highlights the promise that acerola waste holds in anti-inflammatory, antihyperglycemic, and anticancer therapies. By outlining challenges and opportunities, the review emphasizes the untapped potential of acerola waste as a resource for high-value products. These findings suggest a paradigm shift, turning what has been considered waste into a sustainable asset, thereby encouraging environmentally responsible practices within the fruit industry.

The objective of this work was to formulate PVA films with the addition of modified phenols, chitosan, silver, or copper nanoparticles with fungistatic and bacteriostatic activity. The films were characterized by Fourier transform infrared spectroscopy, thermogravimetry analysis, differential scanning calorimetry, and scanning electron microscopy. The bacteriostatic activity against Salmonella gallinarum and Lactobacillus acidophilus, and the fungistatic activity against Penicillium acidophilus were determined. The results indicated that the addition of phenols enhanced the effect on the stability of the chemical structure of the PVA film. PVA films with modified bioactives and nanoparticles inhibited the colonization of the microorganisms tested, indicating germicidal control.

Acerola (Malpighia spp.) is a tropical plant genus of shrubs and trees whose fruit is rich in nutrients and bioactive compounds. However, its production generates significant waste that could pose an environmental issue. This review aims to summarize recent research on the potential uses of acerola wastes, including the extraction of bioactive compounds such as polyphenols, carotenoids, and pectins, as well as the development of materials such as nanomaterials, chitosan, and biofuels. Additionally, the paper discusses the potential medical applications of acerola wastes, such as wound healing, antioxidant, and anticancer effects. Finally, the paper explores the challenges and opportunities of using acerola waste as a sustainable source of raw materials and energy. The findings suggest that acerola waste could be a valuable resource for developing high-value products and promoting sustainable production practices in the fruit industry.

ObjectiveThis work aims to present a Quality-by-Design (QbD) step-by-step methodology to formulate anti-ulcer and gastro-protective oral suspensions.MethodsSucralfate was used as a drug model. The Quality Target Product Profile was established early during preformulation. Viscosity, resuspendability, pH, and density were assessed through the screening of several suspension platforms based on different prototype compositions. A compatibility study between the active pharmaceutical ingredient and the excipients was performed by thermal analysis and infrared spectroscopy. An Ishikawa fishbone diagram and Failure Mode and Effect Analysis were employed to identify the Critical Material Attributes (CMAs), Critical Process Parameters (CPPs), and Critical Quality Attributes (CQAs). CMAs' and CPPs' impact on identified CQAs was further assessed through a 22 full factorial experimental design at normal conditions after manufacture and one month at super-accelerated stress conditions. Results: The lead prototype exhibited no physicochemical incompatibilities. The risk assessment tools revealed that the concentration of the wetting agent and the total concentration of thickening agents represented critical factors for the quality profile of the preparation in terms of viscosity. The optimized formulation comprising 1.125 w/v% total concentration of Natrosol 250 HX and Avicel RC 591 exhibited an enhanced performance according to the established profile.ConclusionsThe analytical and physicochemical tests showed the robustness and compliance of the final preparation with the quality profile. The proposed step-by-step methodology based on QbD, Design of Experiments, and Quality Risk Management presented in our research holds practical implications for local industries and formulation scientists involved in the development of oral suspensions.

Green-synthesized silver nanoparticles (AgNPs) exhibit outstanding antibacterial and antioxidant potential for designing and developing nanomedicines and medical devices. Nephelium lappaceum or rambutan contains polyphenol-based phytochemicals, which suggests its suitability for the green synthesis of NPs. However, the lack of a systematic approach directly impacts the robustness and reproducibility of the process. Design of experiments can address these challenges in obtaining NPs with the desired quality profile. In this work, we demonstrated the advantages of a Plackett–Burman model in the semi-automated green synthesis of AgNPs using N. lappaceum peel extract. The extract concentration was the only significant factor affecting the particle size. The optimized NPs exhibited triangular and hexagonal morphologies and a hydrodynamic diameter of 80 nm after 24 h without a stabilizing agent, representing 1.2% prediction error according to the model’s equation. The in vitro antioxidant capacity was confirmed through the ABTS radical scavenging assay. The AgNPs displayed a minimum inhibitory concentration of 23.5 µg mL⁻¹ against Escherichia coli and Staphylococcus aureus. Overall, this work highlights the synergistic role between a DoE-assisted green synthesis, the phytochemicals from N. lappaceum peel extract, and the formed AgNPs, positioning this systematic approach as a sustainable and efficient process for novel antibacterial and antioxidant agents.